A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 7,846 shares of ILMN stock, worth $1.12 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
7,846
Previous 19,379 59.51%
Holding current value
$1.12 Million
Previous $2.02 Million 49.43%
% of portfolio
0.05%
Previous 0.11%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$105.28 - $135.9 $1.21 Million - $1.57 Million
-11,533 Reduced 59.51%
7,846 $1.02 Million
Q2 2024

Aug 13, 2024

SELL
$101.05 - $133.57 $3.22 Million - $4.26 Million
-31,860 Reduced 62.18%
19,379 $2.02 Million
Q1 2024

May 07, 2024

SELL
$127.73 - $147.2 $12,900 - $14,867
-101 Reduced 0.2%
51,239 $7.04 Million
Q4 2023

Feb 07, 2024

SELL
$92.79 - $142.53 $2.72 Million - $4.19 Million
-29,366 Reduced 36.39%
51,340 $7.15 Million
Q3 2023

Nov 09, 2023

SELL
$128.91 - $192.44 $435,071 - $649,485
-3,375 Reduced 4.01%
80,706 $11.1 Million
Q2 2023

Aug 09, 2023

SELL
$183.43 - $232.67 $615,407 - $780,607
-3,355 Reduced 3.84%
84,081 $15.8 Million
Q1 2023

May 03, 2023

SELL
$193.75 - $232.55 $759,887 - $912,061
-3,922 Reduced 4.29%
87,436 $20.3 Million
Q4 2022

Feb 10, 2023

SELL
$187.24 - $242.74 $634,743 - $822,888
-3,390 Reduced 3.58%
91,358 $18.5 Million
Q3 2022

Nov 08, 2022

SELL
$177.23 - $227.44 $239,792 - $307,726
-1,353 Reduced 1.41%
94,748 $18.1 Million
Q2 2022

Aug 05, 2022

BUY
$181.58 - $368.0 $198,466 - $402,224
1,093 Added 1.15%
96,101 $17.7 Million
Q1 2022

May 11, 2022

BUY
$303.87 - $423.8 $785,200 - $1.1 Million
2,584 Added 2.8%
95,008 $33.2 Million
Q4 2021

Feb 11, 2022

BUY
$347.28 - $421.83 $267,405 - $324,809
770 Added 0.84%
92,424 $35.2 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $601,519 - $778,337
1,483 Added 1.64%
91,654 $37.2 Million
Q2 2021

Aug 12, 2021

BUY
$372.84 - $481.5 $126,019 - $162,747
338 Added 0.38%
90,171 $42.7 Million
Q1 2021

May 07, 2021

BUY
$361.28 - $504.76 $412,220 - $575,931
1,141 Added 1.29%
89,833 $34.5 Million
Q4 2020

Feb 10, 2021

BUY
$292.7 - $370.96 $607,059 - $769,371
2,074 Added 2.39%
88,692 $32.8 Million
Q3 2020

Oct 28, 2020

BUY
$268.51 - $400.74 $821,372 - $1.23 Million
3,059 Added 3.66%
86,618 $26.8 Million
Q2 2020

Aug 14, 2020

BUY
$256.46 - $373.01 $466,757 - $678,878
1,820 Added 2.23%
83,559 $30.9 Million
Q1 2020

May 13, 2020

BUY
$209.2 - $335.53 $601,659 - $964,984
2,876 Added 3.65%
81,739 $22.3 Million
Q4 2019

Feb 14, 2020

BUY
$288.29 - $335.49 $396,975 - $461,969
1,377 Added 1.78%
78,863 $26.2 Million
Q3 2019

Nov 08, 2019

BUY
$266.84 - $378.23 $581,978 - $824,919
2,181 Added 2.9%
77,486 $23.6 Million
Q2 2019

Aug 06, 2019

SELL
$300.59 - $368.15 $573,826 - $702,798
-1,909 Reduced 2.47%
75,305 $27.7 Million
Q1 2019

May 10, 2019

BUY
$272.57 - $321.18 $68,687 - $80,937
252 Added 0.33%
77,214 $24 Million
Q4 2018

Feb 14, 2019

BUY
$272.46 - $366.54 $158,844 - $213,692
583 Added 0.76%
76,962 $23.1 Million
Q3 2018

Nov 26, 2018

SELL
$279.04 - $367.06 $1.19 Million - $1.56 Million
-4,260 Reduced 5.28%
76,379 $28 Million
Q2 2018

Aug 09, 2018

SELL
$228.17 - $292.07 $3.6 Million - $4.61 Million
-15,786 Reduced 16.37%
80,639 $22.5 Million
Q1 2018

Jul 26, 2018

BUY
$209.54 - $253.91 $15.4 Million - $18.7 Million
73,628 Added 322.97%
96,425 $22.8 Million
Q1 2018

May 03, 2018

SELL
$209.54 - $253.91 $12.7 Million - $15.4 Million
-60,807 Reduced 72.73%
22,797 $96.4 Million
Q4 2017

Feb 06, 2018

SELL
$202.23 - $230.03 $393,337 - $447,408
-1,945 Reduced 2.27%
83,604 $0
Q3 2017

Nov 09, 2017

BUY
$172.3 - $213.93 $7,581 - $9,412
44 Added 0.05%
85,549 $17 Million
Q2 2017

Aug 14, 2017

BUY
N/A
85,505
85,505 $14.8 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Reynders Mc Veigh Capital Management, LLC Portfolio

Follow Reynders Mc Veigh Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.